Public health risks from subclinical variant CJD

PLoS Pathogens

Volumn 13, Issue 11, 2017, Pages

  Diack, Abigail B ^a   Will, Robert G ^b   Manson, Jean C ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

ASYMPTOMATIC INFECTION; BIOCHEMICAL ANALYSIS; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CENTRAL NERVOUS SYSTEM; DISEASE SURVEILLANCE; EXPERIMENTAL DISEASE; FOOD CONTAMINATION; FOOD SAFETY; GENOTYPING TECHNIQUE; HEALTH HAZARD; HUMAN; IMMUNOHISTOCHEMISTRY; NONHUMAN; PLASMA; POLYMERASE CHAIN REACTION; POPULATION DISTRIBUTION; PREVALENCE; PROTEIN MISFOLDING; REVIEW; RISK MANAGEMENT; SENSITIVITY AND SPECIFICITY; VARIANT CREUTZFELDT JAKOB DISEASE; VIRUS INFECTIVITY; ANIMAL; CREUTZFELDT JAKOB DISEASE; PUBLIC HEALTH; TRANSMISSION;

ANIMALS; CREUTZFELDT-JAKOB SYNDROME; HUMANS; PUBLIC HEALTH;

EID: 85036557362     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006642     Document Type: Review

References (20)

1. National CJD Research and Surveillance Unit (2017) Creutzfeldt-Jakob disease in the UK. http://www.cjd.ed.ac.uk. Accessed on August 22, 2017.
2. Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, et al. (2006) Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol5: 393–398. doi: 10.1016/S1474-4422(06)70413-6 16632309
3. Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, et al. (2014) Variant CJD. 18 years of research and surveillance. Prion8: 286–295. doi: 10.4161/pri.29237 25495404
4. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW, (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet364: 527–529. doi: 10.1016/S0140-6736(04)16811-6 15302196
5. Bishop MT, Diack AB, Ritchie DL, Ironside JW, Will RG, et al. (2013) Prion infectivity in the spleen of a PRNP heterozygous individual with subclinical variant Creutzfeldt-Jakob disease. Brain136: 1139–1145. 23449776
6. Douet JY, Lacroux C, Aron N, Head MW, Lugan S, et al. (2017) Distribution and Quantitative Estimates of Variant Creutzfeldt-Jakob Disease Prions in Tissues of Clinical and Asymptomatic Patients. Emerg Infect Dis23: 946–956. doi: 10.3201/eid2306.161734 28518033
7. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J, (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet352: 703–704. doi: 10.1016/S0140-6736(98)24035-9 9728989
8. Ironside JW, Bishop MT, Connolly K, Hegazy D, Lowrie S, et al. (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ332: 1186–1188. doi: 10.1136/bmj.38804.511644.55 16606639
9. Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, et al. (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol203: 733–739. doi: 10.1002/path.1580 15221931
10. Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, et al. (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ347.
11. Public Health England (2016) Summary results of the third national survey of abnormal prion prevalence in archived appendix specimens. Health Protection Report 10.
12. Head MW, Ritchie D, Smith N, McLoughlin V, Nailon W, et al. (2004) Peripheral tissue involvement in sporadic, iatrogenic, and variant Creutzfeldt-Jakob disease: an immunohistochemical, quantitative, and biochemical study. Am J Pathol164: 143–153. doi: 10.1016/S0002-9440(10)63105-7 14695328
13. Sawyer EB, Edgeworth JA, Thomas C, Collinge J, Jackson GS, (2015) Preclinical detection of infectivity and disease-specific PrP in blood throughout the incubation period of prion disease. Sci Rep5: 17742. doi: 10.1038/srep17742 26631638
14. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ, (2000) Transmission of BSE by blood transfusion in sheep. Lancet356: 999–1000. 11041403
15. McCutcheon S, Alejo Blanco AR, Houston EF, de Wolf C, Tan BC, et al. (2011) All clinically-relevant blood components transmit prion disease following a single blood transfusion: a sheep model of vCJD. PLoS ONE6: e23169. doi: 10.1371/journal.pone.0023169 21858015
16. Jackson GS, Burk-Rafel J, Edgeworth JA, Sicilia A, Abdilahi S, et al. (2014) A highly specific blood test for vCJD. Blood123: 452–453. doi: 10.1182/blood-2013-11-539239 24434999
17. Lacroux C, Comoy E, Moudjou M, Perret-Liaudet A, Lugan S, et al. (2014) Preclinical detection of variant CJD and BSE prions in blood. PLoS Pathog10: e1004202. doi: 10.1371/journal.ppat.1004202 24945656
18. Bougard D, Brandel JP, Belondrade M, Beringue V, Segarra C, et al. (2016) Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease. Sci Transl Med8: 370ra182. doi: 10.1126/scitranslmed.aag1257 28003547
19. Ritchie DL, Boyle A, McConnell I, Head MW, Ironside JW, et al. (2009) Transmissions of variant Creutzfeldt-Jakob disease from brain and lymphoreticular tissue show uniform and conserved bovine spongiform encephalopathy-related phenotypic properties on primary and secondary passage in wild-type mice. J Gen Virol90: 3075–3082. doi: 10.1099/vir.0.013227-0 19656962
20. Notari S, Moleres FJ, Hunter SB, Belay ED, Schonberger LB, et al. (2010) Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS ONE5: e8765. doi: 10.1371/journal.pone.0008765 20098730